Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 458
  • Print this page
  • Email this page

    Article Cited by others


Nix-TB and ZeNix trials: Paving the way for shorter regimens for drug-resistant tuberculosis

Mishra Gyanshankar

Year : 2021| Volume: 14| Issue : 10 | Page no: 431-432

   This article has been cited by
1 Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury
Heikrujam Nilkanta Meitei, Anupama Pandey, Reena Haobam
Molecular Biology Reports. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Implications of bedaquiline-resistant tuberculosis
Gyanshankar P Mishra, Jasmin Mulani
The Lancet Infectious Diseases. 2022; 22(2): 166
[Pubmed]  [Google Scholar] [DOI]


Read this article